RY10-4, an analog version of proto-apigenone, promotes ACD by inactivation of the AKT/mTOR pathway in the breast cancer cell line MCF-7, and the inhibition of autophagy through genetic and chemical approaches extends cancer cell viability (34). This evidence concerns the gene AKT1 and cancer.